Driving Digital Biomanufacturing Market Growth in 2025: The Role of Accelerating Growth In The Digital Biomanufacturing Market Amid Rising Demand

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Digital Biomanufacturing Market Size Growth Forecast: What to Expect by 2025?
The size of the digital biomanufacturing market has experienced swift expansion of late. Projected growth indicates an increase from $21.11 billion in 2024 to $23.82 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.8%. Previously recorded growth has been driven by factors such as the escalating complexity of biopharmaceuticals, the advent of personalized medicine, an increased demand for affordable production methods, bioprocess optimization, and stringent requirements for quality control and legal compliance.

How Will the Digital Biomanufacturing Market Size Evolve and Grow by 2029?
The digital biomanufacturing sector is forecasted to experience significant expansion in the coming years, with an expected increase to $40.43 billion in 2029, reflecting a Compound Annual Growth Rate (CAGR) of 14.1%. This anticipated growth in the predicted period is due largely to factors such as the implementation of blockchain for supply chain transparency, the use of advanced process control (APC) systems, a focus on sustainability, symbiotic biomanufacturing ecosystems, and biomanufacturing prospects in emerging markets. Dominant trends predicted for this period include the incorporation of artificial intelligence (AI), the development of digital twins for bioprocessing, advancements in biotechnological fields, integration into Industry 4.0, and real-time supervision and management.

View the full report here:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

What Drivers Are Propelling the Growth of Digital Biomanufacturing Market Forward?
The increasing need for biologics is anticipated to spur the expansion of the digital biomanufacturing market. Biologics encompass a large variety of pharmaceuticals such as vaccines, growth factors, immune system regulators, monoclonal antibodies, and medicines derived from human blood and plasma. Digital biomanufacturing is implemented to improve the production of biologics by optimizing processes, maintaining quality, reducing expenses, and diminishing production time. This allows manufacturers to adopt data-centric approaches and sophisticated technology to cater to the escalating demand for biologics more effectively and sustainably. For example, as reported by Cell & Gene, a US-centric online platform for research scholars, in February 2023, there were 27 FDA-approved cell and gene therapies (CGTs). This accounted for around 8% of the 340 authorized biologics in 2022, which was an increase from the 22 that were approved in 2021. Consequently, the rising demand for biologics is fuelling the progress of the digital biomanufacturing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10828&type=smp

Which Emerging Trends Are Transforming the Digital Biomanufacturing Market in 2025?
Leading companies in the market are prioritizing cutting-edge solutions like single-use bioprocessing systems to maintain their competitive advantage. These systems improve digital bio-manufacturing by offering flexibility, instant monitoring, decreased contamination hazards and cost-effectiveness. For example, in October 2022, PharmNXT Biotech LLP, a biotech startup from India, introduced its premier integrated manufacturing unit in Pune, delivering single-use bioprocessing solutions. This state-of-the-art facility was established to overcome the difficulties in biologics production in India. The new unit will create job roles for approximately 100-200 individuals and will serve the needs of international markets, including Singapore, Korea, Europe, and the US. The manufacturing plant will specialize in producing the Xelta line of single-use bioprocessing items and 'NXTmix', a levitating mixing technology.

What Are the Key Segments in the Digital Biomanufacturing Market?
The digital biomanufacturing market covered in this report is segmented -

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types Of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Subsegments:
1) By Manufacturing Technologies: Cell Culture Technologies, Fermentation Technologies, Continuous Manufacturing Processes, Bioreactor Technologies
2) By Analytical And Process Control Technologies: Process Analytical Technology (PAT), Quality Control And Assurance Systems, Real-Time Monitoring Systems, Data Analytics And Visualization Tools
3) By Software: Enterprise Resource Planning (ERP) Systems, Manufacturing Execution Systems (MES), Laboratory Information Management Systems (LIMS), Supply Chain Management Software
4) By Other Types: Robotics And Automation Solutions, Digital Twin Technologies, Internet Of Things (IoT) Solutions For Biomanufacturing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10828&type=smp

Who Are the Key Players Shaping the Digital Biomanufacturing Market's Competitive Landscape?
Major companies operating in the digital biomanufacturing market include Sanofi SA, Thermo Fisher Scientific Inc., Honeywell International Inc., 3M Company, SAP SE, Danaher Corporation, ABB AG, Siemens Healthineers AG, Emerson Electric Co, GE HealthCare Technologies Inc., Atos SE, Agilent Technologies Inc., Cytiva Europe GmbH, Lonza Group AG, Dassault Systèmes SE, Sartorius AG, BioMérieux, Donaldson Company Inc., Pall Corporation, Eppendorf AG, Symphony Innovation LLC, Koch Membrane Systems Inc., Culture Biosciences Inc., Bota Biosciences Inc., Shimadzu Corporation, e-MSion, Exponential Genomics Inc., Immersciobio GmbH

What Geographic Markets Are Powering Growth in the Digital Biomanufacturing Market?
North America was the largest region in the digital biomanufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global digital biomanufacturing market during the forecast period. The regions covered in the digital biomanufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10828

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.